TENAX THERAPEUTICS, INC.
For the period ended Dec 31, 2024. Filed Mar 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 25, 2025
TENX$1.69-5.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. CONSOLIDATED STATEMENTS OF CASH FLOWS
CONS OLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
| Year ended December 31, | |||
|---|---|---|---|
| 2024 · 2023 | |||
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net Loss | $(17,602) | $(7,711) | |
| Adjustments to reconcile net loss to net cash used in operating activities | |||
| Depreciation and amortization | - | 8 | |
| Interest on debt instrument | 23 | 24 | |
| Gain on sale of equipment | - | 1 | |
| Stock-based compensation | 1,125 | 191 | |
| Changes in operating assets and liabilities | |||
| Accounts receivable, prepaid expenses and other assets | 58 | (306) | |
| Accounts payable | 1,062 | 1,652 | |
| Accrued liabilities | 523 | 237 | |
| Net cash used in operating activities | (14,811) | (5,904) | |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Proceeds from sale of property and equipment | - | 3 | |
| Net cash provided by investing activities | - | 3 | |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from issuance of warrants and pre-funded warrants, net of issuance costs | 100,303 | 14,192 | |
| Proceeds from the exercise of warrants | 68 | 1 | |
| Payments on short-term note | (501) | (624) | |
| Net cash provided by financing activities | 99,870 | 13,569 | |
| Net change in cash and cash equivalents | 85,059 | 7,668 | |
| Cash and cash equivalents, beginning of period | 9,792 | 2,124 | |
| Cash and cash equivalents, end of period | $94,851 | $9,792 | |
| Supplemental Disclosures: | |||
| Cash paid for interest | $23 | $24 | |
| Non-cash operating activity | |||
| Addition to prepaids for insurance premium | $ | - | $501 |
| Non-cash financing activity | |||
| Addition to notes payable for financing insurance premium | $ | - | $501 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.